ScholarLens Back to search
2015•China Foreign Medical TreatmentRequires access

The Efficacy and Safety of Etoricoxib and Celecoxib in the Treatment of Acute Gout

Xia Hong-me

Open publisher page 1 citations

Abstract

Objective To investigate the efficacy and safety of etoricoxib and celecoxib in the treatment of acute gout. Methods 80 cases of acute ventilation were selected from April 2013 to June 2014, and were randomly divided into experimental group and control group, 40 cases in each group. In the experimental group were treated with etoricoxib oral treatment; the control group were treated with celecoxib oral treatment. Compare the data of two groups of ventilation patients. Results Two groups of patients with acute gout were treated, the other indicators of the experimental group were better than those of the control group. There were significant differences in VAS score between the two groups after treatment, P0.05, the difference was statistically significant. Conclusion Relying on past exam can effectively in patients with acute gout treatment, which has the advantages of high safety, fast action and so on, worthy of clinical use.

About this research paper

What this paper is about

Objective To investigate the efficacy and safety of etoricoxib and celecoxib in the treatment of acute gout. Methods 80 cases of acute ventilation were selected from April 2013 to June 2014, and were randomly divided into experimental group and control group, 40 cases in each group. In the experimental group were treated with etoricoxib oral treatment; the control group were treated with celecoxib oral treatment. Compare the data of two groups of ventilation patients. Results Two groups of patients with acute gout were treated, the other indicators of the experimental group were better than those of the control group. There were significant differences in VAS score between the two groups after treatment, P0.05, the difference was statistically significant. Conclusion Relying on past exam can effectively in patients with acute gout treatment, which has the advantages of high safety, fast action and so on, worthy of clinical use.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the efficacy and safety of etoricoxib and celecoxib in the treatment of acute gout. Methods 80 cases of acute ventilation were selected from April 2013 to June 2014, and were randomly divided into experimental group and control group, 40 cases in each group. In the experimental group were treated with etoricoxib oral treatment; the control group were treated with celecoxib oral treatment. Compare the data of two groups of ventilation patients. Results Two groups of patients with acute gout were treated, the other indicators of the experimental group were better than those of the control group. There were significant differences in VAS score between the two groups after treatment, P0.05, the difference was statistically significant. Conclusion Relying on past exam can effectively in patients with acute gout treatment, which has the advantages of high safety, fast action and so on, worthy of clinical use.

Key concepts: Medicine, Etoricoxib, Celecoxib, Gout, Clinical efficacy, Anesthesia, Surgery, Internal medicine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
The Efficacy and Safety of Etoricoxib and Celecoxib in the Treatment of Acute Gout — Research Paper | ScholarLens